A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors
Clinical trial NCT06594874 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06594874
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2026-10-31
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.